Conmed (CNMD) Capital Expenditures (2010 - 2026)

Conmed has reported Capital Expenditures for 17 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 23.47% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $18.9 million (up 27.59% YoY), and the FY2025 full-year result was $19.8 million, up 51.38% from the prior year.
• Capital Expenditures for Q1 2026 stood at $2.9 million, down from $5.1 million in the prior quarter.
• The five-year high for Capital Expenditures was $6.7 million in Q3 2022, with the low at $2.0 million in Q1 2024.
• Historically, Capital Expenditures has averaged $4.5 million across 5 years, with a median of $4.5 million in 2023.
• Annual changes were most pronounced in 2022 — Capital Expenditures jumped 90.75% — and 2024, when it tumbled 52.16%.
• Conmed's Capital Expenditures stood at $5.7 million in 2022, then fell by 14.46% to $4.9 million in 2023, then declined by 16.79% to $4.0 million in 2024, then climbed by 26.51% to $5.1 million in 2025, then plunged by 43.42% to $2.9 million in 2026.
• The last three Capital Expenditures figures came in at $2.9 million (Q1 2026), $5.1 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.